Biopsy Site Itching, Tolerance
Conditions
Brief summary
Biopsies are performed in several autoimmune diseases to diagnose or classify them Tolerance and information of the patients have been poorly evlauated our objective is to evaluate tolerance and information of the patients after the biopsies for salivary gland, temporal arteries and neuromuscular.
Detailed description
patinets that benefited of arterial temporal biospy or salivary gland biospy or muscuar biopsy or neuro muscular biospy for his auto -mmune disease will be included and fill standardized questionnaires concerning tolerance, information and side effect at inclusion , day 7 and day 30 after the biopsy data will be analysed to evaluate information, tolerance and risk factor af side effect
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* biospy required for the diagnsis or follow up aged of more than 18 non opposition form
Exclusion criteria
* unable to consent demencia unable to fill the form and questionnaire patient Under juridical protection refusing to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| tolerance of each type of biopsy | tolerance at day 7 after the biospy was performed | tolerance based on a standardized patient 's questionnaire |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| tolerance of each type of biopsy 30 days after | tolerance at day 30 and at inclusion after the biospy was performed | tolerance based on a standardized patient 's questionnaire |
| evaluation of the qualitiy of patient's information at inclusion | questionnaire at inclusion | standardized questionnaire at inclusion |
| risk factor of sied effect of each biospy | standardized questionnaire at inclusion, day 7 and 30 | standardized questionnaire |
Countries
France